Novonesis (Novozymes) B
NSISBC
Kedudukan dalam Saham
#1144
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Harga Saham
$71.06
Modal Pasaran
$19.75B
Perubahan (1 hari)
1.36%
Perubahan (1 tahun)
12.07%
Negara
DK
Perdagangan Novonesis (Novozymes) B (NSISBC)
Kategori
Basic Materials
Nisbah P/B bagi Novonesis (Novozymes) B (NSISBC)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Novonesis (Novozymes) B, nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Novonesis (Novozymes) B dari 2013 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2025 | 15.57 | 1,045.71% |
| 2024 | 1.36 | -81.36% |
| 2023 | 7.29 | 2.90% |
| 2022 | 7.09 | -43.85% |
| 2021 | 12.62 | 44.68% |
| 2020 | 8.73 | 7.14% |
| 2019 | 8.14 | 10.42% |
| 2018 | 7.38 | -21.25% |
| 2017 | 9.37 | 48.84% |
| 2016 | 6.29 | -28.79% |
| 2015 | 8.84 | 21.70% |
| 2014 | 7.26 | 10.46% |
| 2013 | 6.57 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 5.9675 | - |
GB
|
|
| 4.1437 | - |
FR
|
|
| 20.6105 | - |
US
|
|
| 8.0556 | - |
US
|
|
| 4.8569 | - |
US
|
